CANDICE SOTO: Open Payments
NPI 1982335808 · TAVARES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 44 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $189 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $293 |
| ABBVIE INC. | 12 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $109 |
| Phathom Pharmaceuticals, Inc. | 8 | $84 |
| Aimmune Therapeutics, Inc. | 3 | $72 |
| Madrigal Pharmaceuticals | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Ardelyx, Inc. | 1 | $25 |
| Enterra Medical, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
Products named: TREMFYA, XIFAXAN, VOQUEZNA, LINZESS, REZDIFFRA, ZENPEP, CREON, EOHILIA.
Industry payments across FL — which companies pay providers there.
